Clinical Trial Results:
A Phase III, Double-blind, Multi-centre, Randomised, Parallel Group Design, Placebo-controlled, Flexible Dose Study of MCI-196 in Combination with a Calcium-based Phosphate Binder in Chronic Kidney Disease Stage V Subjects on Dialysis with Hyperphosphataemia.
Summary
|
|
EudraCT number |
2006-003324-11 |
Trial protocol |
CZ AT GB FR ES IT DE |
Global completion date |
30 Apr 2009
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
10 Nov 2016
|
First version publication date |
10 Nov 2016
|
Other versions |
|
Summary report(s) |
CSR Synopsis_MCI-196-E09 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.